Clinical Trials Directory

Trials / Completed

CompletedNCT04171609

Expressive Writing for Cancer Survivors

Expressive Writing for Resilience in Adult Cancer Survivors.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
14 (actual)
Sponsor
Duke University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether a 1-day expressive writing intervention for adult cancer survivors improves resilience scores as measured by the Connor-Davidson Resilience Scale (CD-RISC).

Detailed description

The purpose of this study is to determine whether a 1-day expressive writing intervention for adult cancer survivors improves resilience scores as measured by the Connor-Davidson Resilience Scale (CD-RISC).

Conditions

Interventions

TypeNameDescription
BEHAVIORALExpressive writingDuring this daylong expressive writing workshop intervention, the writing instructor coached participants through a series of simple writing exercises. Participation required neither any prior writing experience, nor any desire to become a writer. The practices cultivate natural abilities to express the ideas that define who you are and how you experience your life.

Timeline

Start date
2019-07-19
Primary completion
2020-05-14
Completion
2020-05-14
First posted
2019-11-21
Last updated
2020-08-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04171609. Inclusion in this directory is not an endorsement.

Expressive Writing for Cancer Survivors (NCT04171609) · Clinical Trials Directory